PolyNovo Limited (PNV.AX)
AUD 1.17
(3.54%)
AUD 1.17
(3.54%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 1.16 Million AUD | 118.8% |
| 2023 | -6.18 Million AUD | -2309.81% |
| 2022 | -256.66 Thousand AUD | 91.85% |
| 2021 | -3.14 Million AUD | 23.98% |
| 2020 | -4.14 Million AUD | -17.49% |
| 2019 | -3.52 Million AUD | 43.61% |
| 2018 | -6.24 Million AUD | -21.47% |
| 2017 | -5.14 Million AUD | -45.91% |
| 2016 | -3.52 Million AUD | -17.48% |
| 2015 | -3 Million AUD | 4.73% |
| 2014 | -3.15 Million AUD | 7.94% |
| 2013 | -3.42 Million AUD | 20.65% |
| 2012 | -4.31 Million AUD | -11.34% |
| 2011 | -3.87 Million AUD | -19.93% |
| 2010 | -3.22 Million AUD | -8.59% |
| 2009 | -2.97 Million AUD | 44.93% |
| 2008 | -5.4 Million AUD | 61.32% |
| 2007 | -13.96 Million AUD | -10.96% |
| 2006 | -12.58 Million AUD | -8.88% |
| 2005 | -11.55 Million AUD | 6.51% |
| 2004 | -12.36 Million AUD | -33.83% |
| 2003 | -9.23 Million AUD | -126.23% |
| 2002 | -4.08 Million AUD | -42050.95% |
| 2001 | -9686.00 AUD | 99.73% |
| 2000 | -3.55 Million AUD | -118.08% |
| 1999 | -1.62 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | 1.02 Million AUD | 0.0% |
| 2024 Q2 | -165 Thousand AUD | 0.0% |
| 2024 FY | 1.16 Million AUD | 118.8% |
| 2023 Q4 | -1.91 Million AUD | 0.0% |
| 2023 FY | -6.18 Million AUD | -2309.81% |
| 2023 Q2 | -3.59 Million AUD | 0.0% |
| 2022 Q4 | -1.69 Million AUD | 0.0% |
| 2022 Q2 | 1.77 Million AUD | 0.0% |
| 2022 FY | -256.66 Thousand AUD | 91.85% |
| 2021 FY | -3.14 Million AUD | 23.98% |
| 2021 Q2 | -2.09 Million AUD | 0.0% |
| 2021 Q4 | -1.19 Million AUD | 0.0% |
| 2020 FY | -4.14 Million AUD | -17.49% |
| 2020 Q2 | -2.4 Million AUD | 0.0% |
| 2020 Q4 | -1.67 Million AUD | 0.0% |
| 2019 Q2 | -2.13 Million AUD | 0.0% |
| 2019 Q4 | -1.76 Million AUD | 0.0% |
| 2019 FY | -3.52 Million AUD | 43.61% |
| 2018 FY | -6.24 Million AUD | -21.47% |
| 2018 Q2 | -3.25 Million AUD | 0.0% |
| 2018 Q4 | -2.99 Million AUD | 0.0% |
| 2017 Q2 | -2.06 Million AUD | 0.0% |
| 2017 FY | -5.14 Million AUD | -45.91% |
| 2017 Q4 | -3.07 Million AUD | 0.0% |
| 2016 Q4 | -1.14 Million AUD | 0.0% |
| 2016 Q2 | -2.38 Million AUD | 0.0% |
| 2016 FY | -3.52 Million AUD | -17.48% |
| 2015 FY | -3 Million AUD | 4.73% |
| 2015 Q4 | -1.54 Million AUD | 0.0% |
| 2015 Q2 | -1.45 Million AUD | 0.0% |
| 2014 FY | -3.15 Million AUD | 7.94% |
| 2014 Q4 | -1.9 Million AUD | 0.0% |
| 2014 Q2 | -1.24 Million AUD | 0.0% |
| 2013 Q3 | -855.54 Thousand AUD | -12.31% |
| 2013 Q4 | -973.74 Thousand AUD | -13.82% |
| 2013 FY | -3.42 Million AUD | 20.65% |
| 2013 Q2 | -761.8 Thousand AUD | 29.34% |
| 2013 Q1 | -1.07 Million AUD | 0.0% |
| 2012 Q2 | -1.07 Million AUD | -11.34% |
| 2012 Q1 | -968.3 Thousand AUD | 0.0% |
| 2012 Q4 | -1.07 Million AUD | 0.0% |
| 2012 Q3 | -1.07 Million AUD | 0.0% |
| 2012 FY | -4.31 Million AUD | -11.34% |
| 2011 Q4 | -968.3 Thousand AUD | 0.0% |
| 2011 Q1 | -807.38 Thousand AUD | 0.0% |
| 2011 FY | -3.87 Million AUD | -19.93% |
| 2011 Q3 | -968.3 Thousand AUD | 0.0% |
| 2011 Q2 | -968.3 Thousand AUD | -19.93% |
| 2010 Q2 | -807.38 Thousand AUD | -8.59% |
| 2010 FY | -3.22 Million AUD | -8.59% |
| 2010 Q3 | -807.38 Thousand AUD | 0.0% |
| 2010 Q4 | -807.38 Thousand AUD | 0.0% |
| 2010 Q1 | -743.51 Thousand AUD | 0.0% |
| 2009 FY | -2.97 Million AUD | 44.93% |
| 2009 Q3 | -743.51 Thousand AUD | 0.0% |
| 2009 Q1 | -1.35 Million AUD | 0.0% |
| 2009 Q4 | -743.51 Thousand AUD | 0.0% |
| 2009 Q2 | -743.51 Thousand AUD | 44.93% |
| 2008 Q1 | -3.49 Million AUD | 0.0% |
| 2008 FY | -5.4 Million AUD | 61.32% |
| 2008 Q4 | -1.35 Million AUD | 0.0% |
| 2008 Q3 | -1.35 Million AUD | 0.0% |
| 2008 Q2 | -1.35 Million AUD | 61.32% |
| 2007 Q2 | -3.49 Million AUD | -10.96% |
| 2007 Q4 | -3.49 Million AUD | 0.0% |
| 2007 Q3 | -3.49 Million AUD | 0.0% |
| 2007 FY | -13.96 Million AUD | -10.96% |
| 2007 Q1 | -3.14 Million AUD | 0.0% |
| 2006 Q3 | -3.14 Million AUD | 0.0% |
| 2006 Q4 | -3.14 Million AUD | 0.0% |
| 2006 FY | -12.58 Million AUD | -8.88% |
| 2006 Q2 | -3.14 Million AUD | -8.88% |
| 2006 Q1 | -2.88 Million AUD | 0.0% |
| 2005 Q1 | -3.09 Million AUD | 0.0% |
| 2005 Q4 | -2.88 Million AUD | 0.0% |
| 2005 Q3 | -2.88 Million AUD | 0.0% |
| 2005 Q2 | -2.88 Million AUD | 6.51% |
| 2005 FY | -11.55 Million AUD | 6.51% |
| 2004 Q1 | -2.28 Million AUD | 0.0% |
| 2004 FY | -12.36 Million AUD | -33.83% |
| 2004 Q2 | -3.09 Million AUD | -35.11% |
| 2004 Q4 | -3.09 Million AUD | 0.0% |
| 2004 Q3 | -3.09 Million AUD | 0.0% |
| 2003 Q3 | -2.28 Million AUD | 0.0% |
| 2003 Q4 | -2.28 Million AUD | 0.0% |
| 2003 Q2 | -2.28 Million AUD | -124.1% |
| 2003 Q1 | -1.02 Million AUD | 0.0% |
| 2003 FY | -9.23 Million AUD | -126.23% |
| 2002 Q3 | -1.02 Million AUD | 0.0% |
| 2002 Q4 | -1.02 Million AUD | 0.0% |
| 2002 Q2 | -1.02 Million AUD | -40727.41% |
| 2002 FY | -4.08 Million AUD | -42050.95% |
| 2002 Q1 | -2500.00 AUD | 0.0% |
| 2001 Q3 | -2500.00 AUD | 0.0% |
| 2001 FY | -9686.00 AUD | 99.73% |
| 2001 Q4 | -2500.00 AUD | 0.0% |
| 2001 Q2 | -2500.00 AUD | 99.86% |
| 2001 Q1 | -1.77 Million AUD | 0.0% |
| 2000 FY | -3.55 Million AUD | -118.08% |
| 2000 Q1 | -815.96 Thousand AUD | 0.0% |
| 2000 Q2 | -1.77 Million AUD | -117.97% |
| 2000 Q3 | -1.77 Million AUD | 0.0% |
| 2000 Q4 | -1.77 Million AUD | 0.0% |
| 1999 Q2 | -815.96 Thousand AUD | 0.0% |
| 1999 Q3 | -815.96 Thousand AUD | 0.0% |
| 1999 Q4 | -815.96 Thousand AUD | 0.0% |
| 1999 FY | -1.62 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 104.159% |
| Adherium Limited | -11.98 Million AUD | 109.704% |
| Aroa Biosurgery Limited | -9.78 Million AUD | 111.882% |
| Atomo Diagnostics Limited | -4.36 Million AUD | 126.665% |
| Anteris Technologies Ltd | -66.63 Million AUD | 101.745% |
| Control Bionics Limited | -5.92 Million AUD | 119.615% |
| CardieX Limited | -4.63 Million AUD | 125.099% |
| Compumedics Limited | -269 Thousand AUD | 532.342% |
| Cochlear Limited | 521.5 Million AUD | 99.777% |
| CleanSpace Holdings Limited | -4.81 Million AUD | 124.159% |
| Cyclopharm Limited | -9.22 Million AUD | 112.607% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | 172.039% |
| Nova Eye Medical Limited | -3.79 Million AUD | 130.629% |
| HeraMED Limited | -6.42 Million AUD | 118.093% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 106.617% |
| ImpediMed Limited | -19.03 Million AUD | 106.109% |
| InhaleRx Limited | -1.38 Million AUD | 183.881% |
| LBT Innovations Limited | -4.74 Million AUD | 124.536% |
| Micro-X Limited | -13.02 Million AUD | 108.928% |
| Neurotech International Limited | -5.58 Million AUD | 120.824% |
| OncoSil Medical Limited | -11.98 Million AUD | 109.704% |
| Respiri Limited | -7 Million AUD | 116.614% |
| SomnoMed Limited | -3.84 Million AUD | 130.276% |
| Universal Biosensors, Inc. | -16.68 Million AUD | 106.972% |
| Uscom Limited | -2.4 Million AUD | 148.371% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | 119.866% |